Medicus Pharma (FRA:N460) Loans Receivable: €0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:N460 Medicus Pharma Ltd FRA:N460
12 GF Score
Price €2.46
! 2 Warning Signs
View Full Analysis

What is Medicus Pharma Loans Receivable?

Medicus Pharma FRA:N460 12 Loans Receivable is €0.00 Mil as of Jun. 2026. GuruFocus rates FRA:N460 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Medicus Pharma's Loans Receivable for the quarter that ended in Jun. 2026 was €0.00 Mil.

Medicus Pharma Loans Receivable Historical Data

* Premium members only.

The historical data trend for Medicus Pharma's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicus Pharma Loans Receivable Chart

Medicus Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
0.00 0.00 0.00 0.00 0.00

Medicus Pharma Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:N460
12GF Score
Medicus Pharma Ltd FRA:N460
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicus Pharma Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of €0.00 Mil mean?
Medicus Pharma (FRA:N460) has a Loans Receivable of €0.00 Mil as of Jun. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Medicus Pharma and its competitors.
Is Medicus Pharma's Loans Receivable too high?
Medicus Pharma's current Loans Receivable is €0.00 Mil. Overall, Medicus Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Medicus Pharma's Loans Receivable compare to NSRX and MIRA?
Medicus Pharma's Loans Receivable of €0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Drug Manufacturers company?
A good Loans Receivable depends on the Drug Manufacturers industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Medicus Pharma and its competitors. Medicus Pharma's current Loans Receivable is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicus Pharma stock overvalued right now?
Medicus Pharma (FRA:N460) has a current Loans Receivable of €0.00 Mil. The current Loans Receivable is €0.00 Mil. Medicus Pharma's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Medicus Pharma (FRA:N460), the current Loans Receivable is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicus Pharma Business Description

Other Exchanges MDCX:USA
Address 100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
12GF Score

Get the complete analysis for FRA:N460

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.46
Price